Figure 2 | Scientific Reports

Figure 2

From: Vitreous protein networks around ANG2 and VEGF in proliferative diabetic retinopathy and the differential effects of aflibercept versus bevacizumab pre-treatment

Figure 2

Effect of pre-operative anti-VEGF treatment on VEGFA and PlGF protein concentrations. Box plots indicate median, min and max and 1st and 3rd quartile. Protein concentrations for controls, untreated PDR patients (PDR), PDR patients treated with AFB (AFB) and PDR patients treated with BVZ or RZB (BVZ) are presented as pg/ml in log10 scale. Graphs in the upper row were obtained from array data, graphs in the lower row from ELISA data. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

Back to article page